On December 22, 2023, Cytophage Technologies Inc. closed the transaction. The transaction included participation from 33 placees and 6 existing insiders for 366,000 subscription receipts. In connection with the financing the finder will receive an aggregate cash fee of CAD 42,525.00 and an aggregate of 35,525 finders' warrants.

Each finder's warrant which was exchanged for one resulting issuer finder's warrant, is exercisable until Feb. 2, 2026, to acquire one resulting issuer unit, comprising one resulting issuer share and one-half of one resulting issuer warrant, at a purchase price equal to CAD 1 per resulting issuer finder warrant.